These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10154087)

  • 21. The egg trade--making sense of the market for human oocytes.
    Spar D
    N Engl J Med; 2007 Mar; 356(13):1289-91. PubMed ID: 17392298
    [No Abstract]   [Full Text] [Related]  

  • 22. Better forecasting ensures profitability, quality of care.
    Schmitz V; Masters GM; Dilts W
    Healthc Financ Manage; 1989 Jan; 43(1):60, 62, 64-6. PubMed ID: 10290701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological characteristics and marital quality of infertile women registered for in vitro fertilization-intracytoplasmic sperm injection in China.
    Wang K; Li J; Zhang JX; Zhang L; Yu J; Jiang P
    Fertil Steril; 2007 Apr; 87(4):792-8. PubMed ID: 17222834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compensating egg donors. Is the money worth it?
    Barlyn S
    N J Med; 1999 Sep; 96(9):33-5. PubMed ID: 10502932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Getting in harmony. As markets change, hospitals struggle with pricing.
    Pallarito K
    Mod Healthc; 1997 Jun; 27(26):100-1, 106, 108-11. PubMed ID: 10167960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Data-driven decision-making. Integrating operational, organizational, and clinical benchmark data.
    Healthc Financ Manage; 1997 Mar; 51(3):suppl 1-17. PubMed ID: 10165432
    [No Abstract]   [Full Text] [Related]  

  • 27. Managed competition using both market-driven and regulatory strategies.
    Weil TP
    Manag Care Q; 2002; 10(3):32-40. PubMed ID: 12476663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current differences and consequences of legislation on practice of assisted reproductive technology in the Nordic countries. The Nordic Committee on Assisted Reproduction of the Scandinavian Federation of Societies of Obstetrics and Gynecology.
    Hazekamp JT
    Acta Obstet Gynecol Scand; 1996 Feb; 75(2):198-200. PubMed ID: 8604616
    [No Abstract]   [Full Text] [Related]  

  • 29. The ever-widening gap between the science of artificial reproductive technology and the laws which govern that technology.
    Havins WE; Dalessio JJ
    De Paul Law Rev; 1999; 48(4):825-66. PubMed ID: 12484397
    [No Abstract]   [Full Text] [Related]  

  • 30. Painful medicine: managed care and the fate of America's major teaching hospitals.
    Levey S; Anderson L
    J Healthc Manag; 1999; 44(4):231-49; discussion 249-51. PubMed ID: 10539198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization.
    Xu H; Schultze-Mosgau A; Agic A; Diedrich K; Taylor RN; Hornung D
    Fertil Steril; 2006 Dec; 86(6):1616-20. PubMed ID: 16997300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles.
    Frattarelli JL; Miller KA; Miller BT; Elkind-Hirsch K; Scott RT
    Fertil Steril; 2008 Jul; 90(1):97-103. PubMed ID: 17765235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical aspects of oocyte donation, in vitro fertilization surrogacy and reproductive cloning.
    Hovatta O
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):921-4. PubMed ID: 11081671
    [No Abstract]   [Full Text] [Related]  

  • 34. Developing an effective business plan.
    Lehman LB
    Med Interface; 1996 Jun; 9(6):120-2, 124. PubMed ID: 10157925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economics of hospital obstetrics care.
    Baron DP
    J Econ Bus; 1978; 30(2):98-107. PubMed ID: 10239386
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of in vitro fertilization with intracytoplasmic sperm injection for severe male infertility.
    Pinheiro RC; Lambert J; Bénard F; Mauffette F; Miron P
    CMAJ; 1999 Nov; 161(11):1397-401. PubMed ID: 10906893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare transition managers make market exits easier for insurers.
    Resnick LR
    Healthc Financ Manage; 1999 Oct; 53(10):39-41. PubMed ID: 11066665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-containment strategies for centers offering open heart product lines: one conceptual model.
    Vazquez LT
    J Cardiovasc Manag; 1993; 4(5):24-7. PubMed ID: 10171720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of management in an in vitro fertilization practice.
    Masler S; Strickland RR
    Semin Reprod Med; 2013 May; 31(3):204-10. PubMed ID: 23609151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas.
    Esinler I; Bozdag G; Aybar F; Bayar U; Yarali H
    Fertil Steril; 2006 Jun; 85(6):1730-5. PubMed ID: 16690058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.